Phase 2a clinical trials

GI Cell, a South Korean developer of immune cell therapy products, received a human cell and others management license from South Korean regulatory,...

CJ Bioscience, an independent red bio (pharmaceutical and healthcare) subsidiary of CJ CheilJedang Corp., said on Monday it has submitted a phase 1 ...

Celltrion Ltd. said on Friday it had applied the previous day for permission from the US Food and Drug Administration (FDA) for Remsima SC, an autoi...

JW Pharmaceutical announced through its disclosure on Monday that it had applied last Friday for a phase 3 trial for Epaminurad, a gout treatment, w...

South Korea's leading pharmaceutical company GC Biopharma Corp. said on Thursday that it has confirmed the safety and immunogenicity of the patch-ty...

SK Group's new drug development subsidiary SK Biopharmaceuticals Co. will begin clinical trials for a wearable device that can detect and predict ep...

South Korean biotech company Sillajen Inc. has started recruiting patients for Phase 1 clinical trials in the US for an anti-cancer drug from a Swis...

LG Chem Ltd. announced in a disclosure on Monday that it had confirmed superior efficacy in phase 3 clinical trials for the combined administration ...

South Korean drug developer Onconic Therapeutics, announced on Friday that it raised 26 billion won ($19.9 million) in Series B funding, with cumula...

LS Cable & System Ltd., South Korea’s top wire and cable producer, signed a formal contract worth 150 million euros ($159 million) to supp...

South Korean biopharmaceutical company Celltrion Inc. announced Friday that it won its first trial against New York-based biotech giant Regeneron Ph...

KT Corp., a major South Korean telecom operator, has teamed up with another local company to expand its digital healthcare business in Vietnam furth...

South Korean biopharmaceutical firms are facing challenges in clinical trials overseas alongside the rising Korean won to the US dollar exchange rat...

POSCO Group, which owns South Korea’s largest steelmaker, plans to invest an additional $1.09 billion, or 5 trillion won, in its lithium produ...

A number of veterinary diagnostics companies are struggling to differentiate themselves in the global market. According to Grand View Research Inc.,...

Digital Pharm, jointly invested in by KT Corp. and Hanmi Pharmaceutical Co., held an official inauguration ceremony last week, the company announced...

Samsung Bioepis Co., a biopharmaceutical unit of Samsung Group, said its SB12, a proposed biosimilar to Alexion Pharmaceuticals Inc.’s rare bl...

Imagine making a doctor’s appointment with a click of a button on a smartphone app. Once at the clinic or hospital, the app will guide the use...

South Korean robotics firm Hyundai Robotics Co. announced it signed a letter of intent for a business partnership with global telecommunications gia...

LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., has received the US Food and Drug Administration’s approval for phase 1 cli...

FutureChem Co., a South Korean radiopharmaceutical company, is seeking the US Food and Drug Administration’s approval for clinical tests of it...

Suresofttech Co., a South Korean developer of verification tools for software quality, has won a deal to check a key system in small-size reactors m...

EONE-DIAGNOMICS Genome Center Co. ( EDGC ) announced this week it would participate in AI Human Metaverse Project consortium – along with seven ...

Kolon TissueGene Inc., the cell therapies unit of South Korean pharmaceutical company Kolon Life Science Inc., said on Dec. 28 it has resumed admi...

MedPacto Inc., a South Korean biotechnology company that develops therapeutics for cancer and autoimmune diseases, has agreed with global drugmaker ...

LG Electronics Inc. is expanding its business scope to the medical equipment sector with a plan to unveil a pain-relieving device in an effort to ga...

Citibank Korea has decided to close its consumer banking operations in phases, the bank said on Monday, after its attempt to find a buyer of the bus...

The ongoing global fever over South Korean music and entertainment content is driving the rapid growth of the country’s packaged food manufact...

SK Bioscience Co. has received approval from South Korea’s Ministry of Food and Drug Safety (MFDS) for phase 3 clinical trials of its COVID-19...

South Korean biosimilar maker Celltrion Inc. will launch the first-phase clinical trials of its new COVID-19 treatment candidate next month, followi...